Epithelial cells of different organs exhibit distinct patterns of p53- dependent and p53-independent apoptosis following DNA insult

Experimental Cell Research

Volumn 252, Issue 1, 1999, Pages 123-133

  Uberti, Daniela ^b   Schwartz, Dov ^b   Almog, Nava ^b   Goldfinger, Naomi ^b   Harmelin, Alon ^a   Memo, Maurizio ^b   Rotter, Varda ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NONE

Author keywords

Apoptosis; DNA damage; Epithelial cells; p53

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EPITHELIUM CELL; FEMALE; GENOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN EPITHELIUM; SMALL INTESTINE MUCOSA; TISSUE DISTRIBUTION; TONGUE;

EID: 0033544023     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4606     Document Type: Article

References (42)

1. Glucksmann A. Cell death in normal development. Arch. Biol. (Liege). 76:1965;419-437.
2. Ucker D. S. Death by suicide: One way to go in mammalian cellular development. New Biol. 3:1991;103-109.
3. Zakeri Z., Bursch W., Tenniswood M., Lockshin R. A. Cell death: Programmed, apoptosis, necrosis, or other. Cell Death Differ. 2:1995;87-96.
4. Wyllie A. H. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 5:1995;97-104.
5. Dieckmann T., Withers-Ward E. S., Jarosinski M. A., Liu C. F., Chen I. S., Feigon J. Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vrp. Nature Struct. Biol. 5:1998;1042-1047.
6. Kiess W., Gallaher B. Hormonal control of programmed cell death/apoptosis. Eur. J. Endocrinol. 138:1998;482-491.
7. Lieberthal W., Triaca V., Koh S. J., Pagano P. J., Levine J. S. Role of superoxide in apoptosis induced by growth factor withdrawal. Am. J. Physiol. 275:1998;F691-702.
8. Azizeh B. Y., Cribbs D. H., Kreng V. M. M., Cotman C. W. Cross-linking of NCAM receptors on neurons induced programmed cell death. Brain Res. 796:1998;20-26.
9. Fukai F., Mashimo M., Akiyama K., Goto T., Tanuma S., Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and fibronectin-derived antiadhesive peptide. Exp. Cell Res. 242:1998;92-99.
10. Ward J. F. The complexity of DNA damage: Relevance to biological consequences. Int. J. Radiat. Biol. 66:1994;427-432.
11. Nicholson D. W., Thornberry N. A. Caspases: Killer proteases. TIBS. 22:1997;299-306.
12. Berges R. R., Furuya Y., Remington L., English H. F., Jacks T., Isaacs J. T. Cell proliferation, DNA repair and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. USA. 90:1993;8910-8914.
13. Colombel M., Radvanyi F., Blanche M., Abbou C., Buttyan R., Donehower L. A., Chopin D., Thiery J. P. Androgen suppressed apoptosis is modified in p53 deficient mice. Oncogene. 10:1995;1269-1274.
14. 1 and S phases of the cell cycle without growth arrest or stabilization of wild type p53. Mol. Cell. Biol. 14:1994;4183-4192.
15. Slichenmeyer W. J., Nelson W. G., Slebos R. J., Kastan M. B. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53:1993;4164-4168.
16. Kastan M. B., Zhan Q., El-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunket B. S., Vogelstein B., Fornace A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
17. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
18. Lee J. M., Bernstein A. p53 mutations increase resistance to ionizing irradiation. Proc. Natl. Acad. Sci. USA. 90:1993;5742-5746.
19. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
20. Zhu Y., Bradbury D., Russel N. Wild type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br. J. Cancer. 69:1994;468-472.
21. Lee S., Elenbaas B., Levine A., Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell. 81:1995;1013-1020.
22. Sanchez Y., Elledge J. S. Stopped for repairs. BioAssays. 17:1995;545-548.
23. Donehower L. A., Harvey M., Slagle B. T., McArthur M. J., Montgomery C. A., Butel J. S., Bradly A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
24. Purdie A. C., Harrison J. D., Peter A., Dobbie L., White S., Howie M. E. S., Salter M. D., Bird C. C., Wyllie H. A., Hooper L. M., Clarke R. A. Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene. 9:1994;603-609.
25. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A., Friend S. H. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1990;1233-1238.
26. Srivastava S., Zou Z., Pirollor K., Blattner W., Chang E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 348:1990;747-749.
27. Peled A., Zipori D., Rotter V. Cooperation between p53-dependent and p53-independent apoptotic pathway of myloid cells. Cancer Res. 56:1996;2148-2156.
28. Li R., Sutphin P. D., Schwartz D., Matas D., Almog N., Wolkowicz R., Goldfinger N., Pei H., Prokocimer M., Rotter V. Mutant p53 protein expression interferes with p53-independent apoptotic pathways. Oncogene. 16:1998;3269-3277.
29. Frenkel J., Sherman D., Fein A., Schwartz D., Almog N., Kapon A., Goldfinger N., Rotter V. Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress. Oncogene. 1999.
30. Potten C. S., Al-Barwari S. E., Hume W. J., Searle J. Circadian rhythms of presumptive stem cells in three different epithelia of the mouse. Cell Tissue Kinet. 10:1977;557-568.
31. Hagios C., Lochter A., Bissel M. J. Tissue architecture: The ultimate regulator of epithelial function. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 353:1998;857-570.
32. Lu Q. L., Abel P., Foster C. S., Lalani E. Bcl2: Role in epithelial differentiation and oncogenesis. Hum. Pathol. 27:1996;102-110.
33. Timme T. L., Thompson T. C. Rapid allelotype analysis of p53 knockout mice. BioTechniques. 17:1994;461-463.
34. Wride M. A., Lapchak P. H., Sanders E. J. Distribution of TNF alpha-like proteins correlates with some regions of programmed cell death in the chick embryo. Int. J. Dev. Biol. 38:1994;673-682.
35. Seiberg M., Marthinuss J., Stenn K. S. Changes in expression of apoptosis-associated genes in skin mark early catagen. J. Invest. Dermatol. 104:1995;78-82.
36. Rehberger A. P., Richter K. H., Schwartz D., Goldfinger N., Oskato R., Almog N., Marks F., Rotter V. Differential expression of the regularly spliced p53 and the C-terminal alternatively spliced form in epidermal differentiation. Cell Growth Differ. 8:1997;851-860.
37. Almog N., Rotter V. Involvement of p53 in cell differentiation and Development. Biochim. Biophys. Acta. 1333:1997;F1-F27.
38. Harvey M., McArthur M., Nomtgomery C., Butel J., Bradley A., Donehower L. Spontaneous and carcinogen induced tumorigenesis in p53-deficient mice. Nature Genet. 5:1993;225-229.
39. Harvey M., McArthur J. M., Montgomery A. C. J., Bradley A., Donehower A. L. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7:1993;938-943.
40. Kemp C. J., Donehower L. A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.
41. Clarke A. R., Gledhill S., Hooper L. M., Bird C. C., Wyllie H. A. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene. 9:1994;1767-1773.
42. Merritt A. J., Allen T. D., Potten C. S., Hickman J. A. Apoptosis in small intestinal epithelia from p53-null mice: Evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation. Oncogene. 14:1997;2759-2766.